AVR 0.08% $12.20 anteris technologies ltd

the current study advertised on clinical trial (n = 40) of first...

  1. 234 Posts.
    lightbulb Created with Sketch. 38
    the current study advertised on clinical trial (n = 40) of first time or VIV replacement will add to that information.........data hopefully available in the next 18 months.......

    I agree about the dilution impact - the upside of the anticipated potential pie in the sky dream SP is still there and could (should) exceed the dilution effect....it just may take longer than many of us hope for......
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.